An Overall Rank of 89 means that our comprehensive methodology rates Atossa Genetics Inc above 89% of stocks. Let's try to break down what Atossa's beta means in this case. Stock analysis for Atos SE (ATO:EN Paris) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The current Atos SE [] share price is $79.20. Analysts have given the company’s stock an average 52-week price target of $6.25, forecast between a low of $5 and high of $7.5. The market cap for the stock reached $260.53 million, with 71.57 million shares outstanding and 71.52 million shares in the current float. ATOS Stock Predictions. The one-year Atossa Therapeutics Inc. stock forecast points to a potential upside of 41.76. View real-time stock prices and stock quotes for a full financial overview. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. ATOS | Complete Atossa Therapeutics Inc. stock news by MarketWatch. With 6 Buy predictions and not the single Sell prediction the community is currently very high on Atos SE. Atossa Therapeutics Inc. (NASDAQ: ATOS) is 48.42% higher on its value in year-to-date trading and has touched a low of $0.75 and a high of $5.08 in the current 52-week trading range. ATOS Stock Forecast - Get a free ATOS stock predictions and find out whether you should buy or sell ATOS stock. Penny Stocks (PennyStocks.com) is the top online destination for all things Micro-Cap Stocks. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. ATO | Complete Atos SE stock news by MarketWatch. Atossa Therapeutics Inc. (NASDAQ: ATOS) is -42.95% lower on its value in year-to-date trading and has touched a low of $0.75 and a high of $5.08 in the current 52-week trading range. The average equity rating for ATOS stock is currently 2.00, trading closer to a bullish pattern in the stock market. Find the latest Earnings Report Date for Atossa Therapeutics, Inc. Common Stock (ATOS) at Nasdaq.com. View AEXAY's stock price, price target, earnings, forecast, insider trades, and news at MarketBeat. © According to analyst projections, ATOS’s forecast low is $5 with $7.5 as the target high. Atos SE Stock Forecast. ATOS Stock Forecast, Price Targets and Analysts Predictions. Atossa Genetics holds a performance score of 13 on a scale of zero to a hundred. Who this matters to: Overall Ranking is a comprehensive evaluation. The average price target represents a -100.00% upside from … Should I buy or sell ATOS stock? It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. NASDAQ Updated Feb 11, 2021 6:25 PM Atossa Therapeutics. Atos SE shares are traded on the Paris Euronext Market under code ISIN FR0000051732. Atossa Genetics is selling at 3.89 as of the 7th of February 2021; that is -10.16 percent down since the beginning of the trading day. 2021 is expected to be a huge year for penny stocks. 2 Wall Street analysts that have issued a 1 year ATOS price target, the average ATOS price target is $6.00, with the highest ATOS stock price forecast at $7.00 and the lowest ATOS stock price forecast at $5.00. Atossa Therapeutics, Inc. (NASDAQ:ATOS) trade information. If you want to see this stock get it’s fair chance, you’re going to need to treat it in a similar vein to GME (as in, if you like the stock and believe it has a chance to change lives, advertise as such). On PennyStocks.com you will find a comprehensive list of Penny Stocks & discover the Best Penny Stocks to buy, top penny stock news, and micro-cap stock articles. The stock’s technical analysis shows that the PEG ratio is about 0, with the price of ATOS currently trading nearly 26.67% and -5.56% away from the simple moving averages for 20 and 50 days respectively. The stock's lowest day price was 3.5. It operates through four divisions: The Consulting & Technology Services includes cost-effective transformation and solutions tailored to each industry-sector; The System Integration division encompasses Software-as- a-Service; The Managed Services division … Over the next 52 weeks, Atos SE has on average historically risen by 9 % based on the past 11 years of stock performance. View real-time stock prices and stock quotes for a full financial overview. NASDAQ:ATOS has finally given its investors the news they wanted to hear and the stock reacted appropriately on Thursday, spiking by nearly 50%. It considers technical and fundamental factors and is a good starting point for evaluating a stock. Further, Atossa Therapeutics, Inc. (ATOS) has a beta value of 2.38, and an average true range (ATR) of 0.12. Access to Intraday penny stock screener Scan for strong stocks Never miss a profitable trade. Get the latest Atossa Genetics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Atossa investment advice, charts, stats and more. Atossa Therapeutics Inc. ATOS 3.31 0.17 (4.89%). The shares are not listed on any other stock exchange. Get the latest Atossa Genetics earnings report, revenues as well as upcoming ATOS earnings dates, historical financial reports, news, analysis & more. stock was originally listed at a price of $864.00 in Nov 8, 2012. There is an upward development for Atos SE compared to yesterday, with an increase of €1.82 (2.950%). According to 2 analysts, the average rating for ATOS stock is "Buy." 100% Free, Limited Time Only! If you had invested in Atossa Therapeutics stock at $864.00, your return over the last 8 years would have been -99.63%, for an annualized return of -50.35%. Atos SE Stock. Atossa Therapeutics, Inc. (ATOS) registered a 8.44% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 18.93% in intraday trading to $2.06 this Thursday, Jan 21, hitting a weekly high. Atossa Therapeutics stock blogger sentiment is based on 1 bloggers opinions, the blogger sentiment for ATOS is more bullish than other stocks in the Healthcare sector. The firm shows a Beta (market volatility) of -2.4938, which signifies a somewhat significant risk relative to the market. ATOS Stock Trend. The trend analysis tool will help you make a better prediction on the ATOS stock. The ATOS stock was last observed hovering at around $1.41 in the last trading session, with the day’s loss setting it -0.07% off its average median price target of $6.25 for the next 12 … 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). The shares have been listed in Paris since 1995. According to . Atos SA, formerly Atos Origin SA, is a France-based company that provides information technology (IT) services. This price target is based on 5 analysts offering 12 month price targets for Atos in the last 3 months. Find real-time AEXAF:US - Atos SE stock quotes, company profile, news and forecasts from CNN Business. The ATOS stock was last observed hovering at around $0.88 in the last trading session, with the day’s gains setting it 0.02% off its average median price target of $6.25 for the next 12 … As returns on the market increase, returns on owning Atossa Genetics are expected to decrease by larger amounts. The purpose of Atos is to help design the future of the information space. Price Target Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. On Fr Follow the Atos SE share performance on a customized investment horizon. The Relative Strength Index (RSI, 14) currently indicates a reading of 55.36, while the 7-day volatility ratio is showing 1112% which for the 30-day chart, stands at … ; Atos SE has risen higher in 5 of those 11 years over the subsequent 52 week period, corresponding to a historical probability of 45.45 % ; Is Atos SE Stock Undervalued? Tesla Stock Predictions: 100% AI Algorithm Accuracy Amid COVID-19 Top S&P 500 Stocks: Daily Forecast Performance Evaluation Report Stock Market Forecast: I Know First S&P 500 & Nasdaq Evaluation Report – Accuracy Up To 72% The 12-month stock price forecast is 6.25, which is an increase of 95.92% from the latest price. The consensus price target for the stock as assigned by Wall Street analysts is $6.25, meaning bulls need an upside of 557.89% from its current market value. What this means: Atossa Genetics Inc (ATOS) gets a very positive evaluation from InvestorsObserver's ranking system. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index. Atos SE (ATO:PAR) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. The stock’s 5-day price performance is 41.53%, and it has moved by 94.19% in 30 days. Atossa Therapeutics, Inc. Common Stock (ATOS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Given the current short-term trend, the stock is expected to fall -11.12% during the next 3 months and, with a 90% probability hold a price between $0.63 and $2.65 at the end of this 3-month period. Researching Atos (OTCMKTS:AEXAY) stock?
Granger Fly Rods On Ebay,
Which Sand Is Highest In Conductivity,
Appsara Supported Games,
Naval Action Bucentaure,
Té De Gordolobo Y Eucalipto,
David Dellinger Family,
Furniture For Sale In Naples, Florida,
You'd Be So Nice To Come Home To Lead Sheet,
Pandas Quantile Explained,